Traditionally, mid-to-large sized public companies stick to their knittting. A biotech company stays in biotech, a weed company stays in weed, a gold company shies away from oil and…
Chris’ Corner
In my opinion, journalism – actual journalism – isn’t just about reporting what you see that’s wrong in the world, but working to get the things that are wrong…..
Liquor e-commerce platform LQR House (LQR.Q) made a bold but carefully worded announcement in January of this year that seemed like one of the greatest deals ever. A $1…
What a time to be alive; there was a period in our civilized history where getting alcohol on a Sunday was a tough racket, now we’re exploring the safe…
A few days ago, Standard Uranium (STND.V) closed a private placement financing at $0.05. By Friday, their stock closed at $0.065, up 30% with volume building. Over the last…
For my first article of the New Year in 2024, I wanted to bring you all something special – something worthy of the top spot. Not a deal that…
Little old Ashley Gold Corp. (ASHL.C), a budding resource company with a growing reputation for doing a lot with a little, recently took a significant step in expanding its…
There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics…
The Saudis just bought golf. Not a golf tournament. Not even a golf league or a resort. But, like, golf. The whole enchilada. They’ve pretty much bought mixed martial…
If you’ve been around here for a while, like going back three years or so ago, you may recall a former client company in Perimeter Medical Imaging (PINK.V). I…